Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Bouley

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Allergy and Clinical Immunology|April 3, 2012
A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapyAline Zimmer, Julien Bouley, Maxime Le Mignon, et al.
Oncotarget|September 5, 2015
A new phosphorylated form of Ku70 identified in resistant leukemic cells confers fast but unfaithful DNA repair in cancer cell linesJulien Bouley, Lina Saad, Romain Grall, et al.
Frontiers in Immunology|June 28, 2021
OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against InfluenzaJudith Del Campo, Julien Bouley, Marion Chevandier, et al.
NPJ Vaccines|February 1, 2019
OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypesJudith Del Campo, Andres Pizzorno, Sophia Djebali, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2015
Identification of the cysteine protease Amb a 11 as a novel major allergen from short ragweedJulien Bouley, Rachel Groeme, Maxime Le Mignon, et al.
International Archives of Allergy and Immunology|January 31, 2012
Expression and characterization of natural-like recombinant Der p 2 for sublingual immunotherapyVéronique Bordas-Le Floch, Laetitia Bussières, Sabi Airouche, et al.
The Journal of Allergy and Clinical Immunology|December 15, 2016
Sialylated Fetuin-A as a candidate predictive biomarker for successful grass pollen allergen immunotherapyNoémie Caillot, Julien Bouley, Karine Jain, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Allergy and Clinical Immunology|April 3, 2012
A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapyAline Zimmer, Julien Bouley, Maxime Le Mignon, et al.
Oncotarget|September 5, 2015
A new phosphorylated form of Ku70 identified in resistant leukemic cells confers fast but unfaithful DNA repair in cancer cell linesJulien Bouley, Lina Saad, Romain Grall, et al.
Frontiers in Immunology|June 28, 2021
OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against InfluenzaJudith Del Campo, Julien Bouley, Marion Chevandier, et al.
NPJ Vaccines|February 1, 2019
OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypesJudith Del Campo, Andres Pizzorno, Sophia Djebali, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2015
Identification of the cysteine protease Amb a 11 as a novel major allergen from short ragweedJulien Bouley, Rachel Groeme, Maxime Le Mignon, et al.
International Archives of Allergy and Immunology|January 31, 2012
Expression and characterization of natural-like recombinant Der p 2 for sublingual immunotherapyVéronique Bordas-Le Floch, Laetitia Bussières, Sabi Airouche, et al.
The Journal of Allergy and Clinical Immunology|December 15, 2016
Sialylated Fetuin-A as a candidate predictive biomarker for successful grass pollen allergen immunotherapyNoémie Caillot, Julien Bouley, Karine Jain, et al.
Pageof 2